Evidence map›Paper›PMID 35016994›Full record

ArticleExperimental neurology2022

DyNeuMo Mk-1: Design and pilot validation of an investigational motion-adaptive neurostimulator with integrated chronotherapy.

Mayela Zamora, Robert Toth, Francesca Morgante, Jon Ottaway, Tom Gillbe, Sean Martin, Guy Lamb, Tara Noone, Moaad Benjaber, Zachary Nairac and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Experimental neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Adaptive Deep Brain Stimulation for Parkinson's Disease: Navigating the Roadblocks to Clinical Implementation.Movement disorders : official journal of the Movement Disorder Society · 2026
    Review
  3. Article
  4. Review
  5. Prediction of Pathological Subthalamic Nucleus Beta Burst Occurrence in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. On brain stimulation in epilepsy.Brain : a journal of neurology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Development and Evaluation of a Real-Time Phase-Triggered Stimulation Algorithm for the CorTec Brain Interchange.IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society · 2024
    Article
  14. Bioelectronic Zeitgebers: targeted neuromodulation to re-establish circadian rhythms.Conference proceedings. IEEE International Conference on Systems, Man, and Cybernetics · 2023
    Article
  15. An embedded intracranial seizure monitor for objective outcome measurements and rhythm identification.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2023
    Article
  16. Spectral Topography of the Subthalamic Nucleus to Inform Next-Generation Deep Brain Stimulation.Movement disorders : official journal of the Movement Disorder Society · 2023
    Article
  17. Open Mind Neuromodulation Interface for the CorTec Brain Interchange (OMNI-BIC): an investigational distributed research platform for next-generation clinical neuromodulation research.International IEEE/EMBS Conference on Neural Engineering : [proceedings]. International IEEE EMBS Conference on Neural Engineering · 2023
    Article
  18. Computationally efficient neural network classifiers for next generation closed loop neuromodulation therapy - a case study in epilepsy.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Mayela ZamoraInstitute of Biomedical Engineering, Department of Engineering Sciences, University of Oxford, Oxford, United Kingdom; MRC Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom. Electronic address: mayela.zamora@eng.ox.ac.uk.
Robert TothMRC Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Francesca MorganteNeurosciences Research Centre, Molecular and Clinical Sciences Research Institute, St George's, University of London, London, United Kingdom; Department of Neurosurgery, Atkinson Morley Regional Neurosciences Centre, St George's Hospital, London, United Kingdom.
Jon OttawayBioinduction Ltd., Bristol, United Kingdom.
Tom GillbeBioinduction Ltd., Bristol, United Kingdom.
Sean MartinDepartment of Neurosurgery, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Guy LambBioinduction Ltd., Bristol, United Kingdom.
Tara NooneBioinduction Ltd., Bristol, United Kingdom.
Moaad BenjaberInstitute of Biomedical Engineering, Department of Engineering Sciences, University of Oxford, Oxford, United Kingdom; MRC Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Zachary NairacInstitute of Biomedical Engineering, Department of Engineering Sciences, University of Oxford, Oxford, United Kingdom.
Devang SehgalInstitute of Biomedical Engineering, Department of Engineering Sciences, University of Oxford, Oxford, United Kingdom.
Timothy G ConstandinouDepartment of Electrical and Electronic Engineering, Imperial College London, London, United Kingdom; Care Research and Technology Centre, UK Dementia Research Institute, London, United Kingdom.
Jeffrey HerronDepartment of Neurological Surgery, University of Washington, Seattle, WA, USA.
Tipu Z AzizDepartment of Neurosurgery, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Ivor GillbeBioinduction Ltd., Bristol, United Kingdom.
Alexander L GreenDepartment of Neurosurgery, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Erlick A C PereiraNeurosciences Research Centre, Molecular and Clinical Sciences Research Institute, St George's, University of London, London, United Kingdom; Department of Neurosurgery, Atkinson Morley Regional Neurosciences Centre, St George's Hospital, London, United Kingdom.
Timothy DenisonInstitute of Biomedical Engineering, Department of Engineering Sciences, University of Oxford, Oxford, United Kingdom; MRC Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom. Electronic address: timothy.denison@eng.ox.ac.uk.
Bioinduction (United Kingdom) · GBUniversity of Oxford · GBMRC Brain Network Dynamics Unit · GBAtkins (United Kingdom) · GBJohn Radcliffe Hospital · GBSt George's, University of London · GBUK Dementia Research Institute · GBUniversity of Washington · US

Funding

Medical Research Council MC_PC_18059Medical Research Council MC_UU_00003/3Medical Research Council UKDRI-7004
6 · The paper itself

Abstract

There is growing interest in using adaptive neuromodulation to provide a more personalized therapy experience that might improve patient outcomes. Current implant technology, however, can be limited in its adaptive algorithm capability. To enable exploration of adaptive algorithms with chronic implants, we designed and validated the 'Picostim DyNeuMo Mk-1' (DyNeuMo Mk-1 for short), a fully-implantable, adaptive research stimulator that titrates stimulation based on circadian rhythms (e.g. sleep, wake) and the patient's movement state (e.g. posture, activity, shock, free-fall). The design leverages off-the-shelf consumer technology that provides inertial sensing with low-power, high reliability, and relatively modest cost. The DyNeuMo Mk-1 system was designed, manufactured and verified using ISO 13485 design controls, including ISO 14971 risk management techniques to ensure patient safety, while enabling novel algorithms. The system was validated for an intended use case in movement disorders under an emergency-device authorization from the Medicines and Healthcare Products Regulatory Agency (MHRA). The algorithm configurability and expanded stimulation parameter space allows for a number of applications to be explored in both central and peripheral applications. Intended applications include adaptive stimulation for movement disorders, synchronizing stimulation with circadian patterns, and reacting to transient inertial events such as posture changes, general activity, and walking. With appropriate design controls in place, first-in-human research trials are now being prepared to explore the utility of automated motion-adaptive algorithms.

Indexed as

BrainMovement DisordersAlgorithmsChronotherapyHumansReproducibility of ResultsActivity recognitionAdaptive controlBrain stimulationClosed-loop systemsNeural implantsRisk management

Identifiers

PMID35016994
PMCPMC7612891
OpenAlexW4220787531

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.